Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel
NYSE:RFL

Rafael Q2 2026 Earnings Report

Rafael logo
$1.93 -0.09 (-4.65%)
Closing price 09/24/2026 03:58 PM Eastern
Extended Trading
$1.91 -0.02 (-0.83%)
As of 07:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Rafael EPS Results

Actual EPS
-$0.13
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Rafael Revenue Results

Actual Revenue
$0.21 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Rafael Announcement Details

Quarter
Q2 2026
Date
3/16/2026
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Rafael's Q4 2026 earnings is estimated for Wednesday, October 28, 2026, based on past reporting schedules

Conference Call Resources

Powered by Quartr

Earnings Documents

Rafael's Q2 2026 Press ReleasePress Release
(8-K)
Rafael's Q2 2026 Quarterly reportQuarterly report
(10-Q)

Rafael Earnings Headlines

ANI Pharmaceuticals (NASDAQ:ANIP) & Rafael (NYSE:RFL) Head to Head Contrast
September 15, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31023728
Rafael Holdings Inc Share Price (RFL.US)
July 15, 2026  |  lse.co.ukhttps://www.lse.co.uk/SharePrice.html?shareprice=RFL.US
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
September 25 at 1:00 AM  |  Stansberry Research (Ad)
Rafael Holdings Insider Trading Activity | NYSE:RFL | Benzinga
July 2, 2026  |  benzinga.comhttps://www.benzinga.com/quote/RFL/insider-trades
Rafael Holdings: The Second Half Of Calendar 2026 Could Define This Company Forever
June 29, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4918451-rafael-holdings-second-half-of-calendar-2026-could-define-this-company
Rafael Holdings (NYSE:RFL) Stock, Short Interest Report
June 25, 2026  |  benzinga.comhttps://www.benzinga.com/quote/RFL/short-interest
See More Rafael Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rafael? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rafael and other key companies, straight to your email.

About Rafael

Rafael (NYSE:RFL) is a diversified holding company focused primarily on commercial real estate and life sciences. The company’s real estate activities include ownership and management of commercial properties, with a focus on properties in the New York metropolitan area and other strategic locations.

Through its life sciences investments and subsidiaries, Rafael Holdings has supported the development of oncology treatments and other pharmaceutical technologies. Its best-known biotechnology subsidiary, Rafael Pharmaceuticals, developed investigational cancer therapies, including devimistat, a treatment designed to target cancer-cell metabolism. These programs have been evaluated in clinical studies, although investigational products remain subject to regulatory approval and may not become commercially available.

Rafael Holdings was established following the separation of certain assets from IDT Corporation. The company is associated with entrepreneur Howard S. Jonas, who has played a significant leadership role in its development. Its operations and investments span commercial real estate and biotechnology, with activities primarily connected to the United States.

View Rafael Profile
Earnings Tools